ARCHIVES

FDA Approves Imaging Agent For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Columbia To Host U.S.- China Conference

February 15, 1980

Nucynta ER Approved For Managing Chronic Pain In Adults

September 30, 2011

Cancer Caused By Environmental Exposure “Grossly Underestimated,” Cancer Panel Says.

May 7, 2010

CDC Offers Funds For 5-A-Day Program; CDC PA Available

May 14, 1999

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow

June 16, 1995